Consent Action of the Board of Directors of Electromedical Technologies, Inc. Amending Consulting Agreement with Robert L. Hymers, III
Electromedical Technologies, Inc., through its sole director Matthew N. Wolfson, approved an amendment to its Consulting Agreement with Robert L. Hymers, III. The amendment grants Mr. Hymers an additional 43,461 shares of restricted common stock, valued at $0.71 per share. The board also directed Pacific Stock Transfer to issue these shares to Mr. Hymers. This action was taken on June 28, 2019, and no further board business was conducted at that time.
Exhibit 10.33
CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES, INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, ("the Company"), hereby unanimously consents to the following actions taken by the Company on June 28, 2019. RESOLVED: To amend the Company's Consulting Agreement dated February 11, 2019 by and between the Company and Robert L. Hymers, III to provide for the issuance of an additional 43,461 shares of the Company restricted common stock valued at $0.71 per share. RESOLVED: That Pacific Stock Transfer is hereby instructed to issue 43,461 shares of the Company's restricted common stock to Robert L. Hymers, III. There being no further business requiring board action or consideration, on motion duly made, and carried, the meeting was adjourned. Matthew N. Wolfson Sole Director
